M
Mary Pinder-Schenck
Researcher at University of South Florida
Publications - 12
Citations - 2154
Mary Pinder-Schenck is an academic researcher from University of South Florida. The author has contributed to research in topics: Lung cancer & Docetaxel. The author has an hindex of 8, co-authored 12 publications receiving 1956 citations.
Papers
More filters
Journal ArticleDOI
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
Scott N. Gettinger,Leora Horn,Leena Gandhi,David R. Spigel,Scott J. Antonia,Naiyer A. Rizvi,John D. Powderly,Rebecca S. Heist,Richard D. Carvajal,David M. Jackman,Lecia V. Sequist,David Smith,Philip D. Leming,David P. Carbone,Mary Pinder-Schenck,Suzanne L. Topalian,F. Stephen Hodi,Jeffrey A. Sosman,Mario Sznol,David F. McDermott,Drew M. Pardoll,Vindira Sankar,Christoph Matthias Ahlers,Mark E. Salvati,Jon M. Wigginton,Matthew D. Hellmann,Georgia Kollia,Ashok Kumar Gupta,Julie R. Brahmer +28 more
TL;DR: Nivolumab monotherapy produced durable responses and encouraging survival rates in patients with heavily pretreated NSCLC, and overall survival, response durability, and long-term safety were reported.
Journal ArticleDOI
Malignant pleural mesothelioma.
David S. Ettinger,Wallace Akerley,Hossein Borghaei,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Apar Kishor Ganti,Ramaswamy Govindan,Frederic W. Grannis,Leora Horn,Thierry Jahan,Mohammad Jahanzeb,Anne Kessinger,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Inga T. Lennes,Billy W. Loo,Renato Martins,Janis P. O'Malley,Raymond U. Osarogiagbon,Gregory A. Otterson,Jyoti D. Patel,Mary Pinder-Schenck,Katherine M.W. Pisters,Karen L. Reckamp,Gregory J. Riely,Eric M. Rohren,Scott J. Swanson,Douglas E. Wood,Stephen C. Yang +33 more
TL;DR: These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on malignant pleural mesothelioma (MPM), which is the most common type.
Journal ArticleDOI
Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines
David S. Ettinger,Wallace Akerley,Hossein Borghaei,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Ramaswamy Govindan,Frederic W. Grannis,Stefan C. Grant,Leora Horn,Thierry Jahan,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Rudy P. Lackner,Inga T. Lennes,Billy W. Loo,Renato Martins,Gregory A. Otterson,Jyoti D. Patel,Mary Pinder-Schenck,Katherine M.W. Pisters,Karen L. Reckamp,Gregory J. Riely,Eric M. Rohren,Theresa A. Shapiro,Scott J. Swanson,Kurt Tauer,Douglas E. Wood,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +34 more
TL;DR: This topic was the subject of a major update in the 2013 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer.
Journal ArticleDOI
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
Gerold Bepler,Gerold Bepler,Charles Williams,Michael J. Schell,Wei Chen,Zhong Zheng,George R. Simon,Shirish M. Gadgeel,Xiuhua Zhao,Fred Schreiber,Julie R. Brahmer,Alberto Chiappori,Tawee Tanvetyanon,Mary Pinder-Schenck,Jhanelle E. Gray,Eric B. Haura,Scott J. Antonia,Juergen R. Fischer +17 more
TL;DR: This demonstrates that protein expression analysis for therapeutic decision making is feasible in newly diagnosed patients with advanced-stage NSCLC and safe, required, and acceptable to 89% (47 of 53) of patients.
Journal ArticleDOI
Thymomas and thymic carcinomas
David S. Ettinger,Gregory J. Riely,Wallace Akerley,Hossein Borghaei,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Ramaswamy Govindan,Frederic W. Grannis,Stefan C. Grant,Leora Horn,Thierry Jahan,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Rudy P. Lackner,Inga T. Lennes,Billy W. Loo,Renato Martins,Gregory A. Otterson,Jyoti D. Patel,Mary Pinder-Schenck,Katherine M.W. Pisters,Karen L. Reckamp,Eric M. Rohren,Theresa A. Shapiro,Scott J. Swanson,Kurt Tauer,Douglas E. Wood,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +34 more
TL;DR: These guidelines outline the evaluation, treatment, and management of mediastinal tumors, including thymomas and thymic carcinomas, which originate in the thymus.